{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:24Z","timestamp":1792801764596,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200393"],"award-info":[{"award-number":["82200393"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970315"],"award-info":[{"award-number":["81970315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Research Center for Interventional Medicine Grant","award":["19MC1910300"],"award-info":[{"award-number":["19MC1910300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiac dysfunction, including arrhythmias, may be one of the main clinical manifestations of Becker muscular dystrophy (BMD). Amiodarone is widely used to treat arrhythmia. However, multi-systemic toxicity caused by amiodarone, especially hepatotoxicity, should not be neglected. Here, we introduce a novel case of multi-systemic amiodarone toxicity involving the liver, renal and coagulation in BDM patient with <jats:italic>ABCB4<\/jats:italic> gene mutation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a case of a 16-year-old boy admitted with heart failure and atrial fibrillation (AF). He was diagnosed with Becker muscular dystrophy (BMD) and gene testing showed comorbid mutations in gene <jats:italic>DMD<\/jats:italic>, <jats:italic>ABCB4<\/jats:italic> and <jats:italic>DSC2<\/jats:italic>. Amiodarone was prescribed to control the paroxysmal atrial fibrillation intravenously. However, his liver enzyme levels were sharply elevated, along with cardiac shock, renal failure and coagulation disorders. After bedside continuous renal replacement therapy, the patient\u2019s liver function and clinical status rehabilitated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>ABCB4<\/jats:italic> gene mutation might be involved in amiodarone-induced hepatotoxicity. Studies in a cohort might help to prove this hypothesis in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-024-02869-7","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T04:01:34Z","timestamp":1721707294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute hepatotoxicity of intravenous amiodarone in a Becker muscular dystrophy patient with decompensated heart failing and ABCB4 gene mutation: as assessed for causality using the updated RUCAM"],"prefix":"10.1186","volume":"19","author":[{"given":"Hui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"issue":"6","key":"2869_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919\u201328. https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4.","journal-title":"Cell"},{"issue":"6","key":"2869_CR2","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","volume":"155","author":"DM Connuck","year":"2008","unstructured":"Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2008;155(6):998\u20131005. https:\/\/doi.org\/10.1016\/j.ahj.2008.01.018.","journal-title":"Am Heart J"},{"issue":"1","key":"2869_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","volume":"17","author":"C Lang","year":"2007","unstructured":"Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics. 2007;17(1):47\u201360. https:\/\/doi.org\/10.1097\/01.fpc.0000230418.28091.76.","journal-title":"Pharmacogenet Genomics"},{"issue":"31","key":"2869_CR4","doi-asserted-by":"publisher","first-page":"23530","DOI":"10.1074\/jbc.M909002199","volume":"275","author":"AJ Smith","year":"2000","unstructured":"Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, et al. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping. J Biol Chem. 2000;275(31):23530\u20139. https:\/\/doi.org\/10.1074\/jbc.M909002199.","journal-title":"J Biol Chem"},{"key":"2869_CR5","doi-asserted-by":"publisher","unstructured":"Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci 2015, 17(1). https:\/\/doi.org\/10.3390\/ijms17010014.","DOI":"10.3390\/ijms17010014"},{"issue":"9307","key":"2869_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery AE. The muscular dystrophies. Lancet. 2002;359(9307):687\u201395. https:\/\/doi.org\/10.1016\/S0140-6736(02)07815-7.","journal-title":"Lancet"},{"issue":"10","key":"2869_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nmd.2021.08.004","volume":"31","author":"F Fortunato","year":"2021","unstructured":"Fortunato F, Farne M, Ferlini A. The DMD gene and therapeutic approaches to restore dystrophin. Neuromuscul Disord. 2021;31(10):1013\u201320. https:\/\/doi.org\/10.1016\/j.nmd.2021.08.004.","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"2869_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","volume":"7","author":"S Mavrogeni","year":"2015","unstructured":"Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G. Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol. 2015;7(7):410\u20134. https:\/\/doi.org\/10.4330\/wjc.v7.i7.410.","journal-title":"World J Cardiol"},{"key":"2869_CR9","doi-asserted-by":"publisher","unstructured":"Kamdar F, Garry DJ. Dystrophin-Deficient Cardiomyopathy. J Am Coll Cardiol. 2016;67(21):2533\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.081.","DOI":"10.1016\/j.jacc.2016.02.081"},{"issue":"10","key":"2869_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s10038-020-0788-9","volume":"65","author":"R Komaki","year":"2020","unstructured":"Komaki R, Hashimoto Y, Mori-Yoshimura M, Oya Y, Takizawa H, Minami N, et al. Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +\u20091G\u2009>\u2009A DMD splice-site mutation: a case report. J Hum Genet. 2020;65(10):903\u20139. https:\/\/doi.org\/10.1038\/s10038-020-0788-9.","journal-title":"J Hum Genet"},{"issue":"12","key":"2869_CR11","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1161\/01.cir.94.12.3168","volume":"94","author":"P Melacini","year":"1996","unstructured":"Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, et al. Myocardial involvement is very frequent among patients affected with subclinical Becker\u2019s muscular dystrophy. Circulation. 1996;94(12):3168\u201375. https:\/\/doi.org\/10.1161\/01.cir.94.12.3168.","journal-title":"Circulation"},{"issue":"5","key":"2869_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1378\/chest.08-1071","volume":"134","author":"RT Stravitz","year":"2008","unstructured":"Stravitz RT. Critical management decisions in patients with acute liver failure. Chest. 2008;134(5):1092\u2013102. https:\/\/doi.org\/10.1378\/chest.08-1071.","journal-title":"Chest"},{"issue":"2","key":"2869_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","volume":"7","author":"A Xanthopoulos","year":"2019","unstructured":"Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019;7(2):87\u201397. https:\/\/doi.org\/10.1016\/j.jchf.2018.10.007.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"2869_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cardfail.2014.03.003","volume":"20","author":"VM van Deursen","year":"2014","unstructured":"van Deursen VM, Edwards C, Cotter G, et al. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study. J Card Fail. 2014;20(6):407\u201313. https:\/\/doi.org\/10.1016\/j.cardfail.2014.03.003.","journal-title":"J Card Fail"},{"issue":"6","key":"2869_CR15","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1177\/147323000903700631","volume":"37","author":"X Huang","year":"2009","unstructured":"Huang X, Yang Y, Zhu J, Gao X, Wang G, Tan H, et al. Clinical applications and acute hepatotoxicity of intravenous amiodarone. J Int Med Res. 2009;37(6):1928\u201336. https:\/\/doi.org\/10.1177\/147323000903700631.","journal-title":"J Int Med Res"},{"issue":"4","key":"2869_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2143\/AC.60.4.2004996","volume":"60","author":"J Finsterer","year":"2005","unstructured":"Finsterer J, Gelpi E, Stollberger C. Left ventricular hypertrabeculation\/ noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation. Acta Cardiol. 2005;60(4):445\u20138. https:\/\/doi.org\/10.2143\/AC.60.4.2004996.","journal-title":"Acta Cardiol"},{"issue":"1","key":"2869_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.ccm.0000151048.72393.44","volume":"33","author":"AE Ratz Bravo","year":"2005","unstructured":"Ratz Bravo AE, Drewe J, Schlienger RG, Krahenbuhl S, Pargger H, Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med. 2005;33(1):128\u201334. https:\/\/doi.org\/10.1097\/01.ccm.0000151048.72393.44. discussion 245\u2009\u2013\u2009126.","journal-title":"Crit Care Med"},{"key":"2869_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2147\/DHPS.S48640","volume":"5","author":"M Nasser","year":"2013","unstructured":"Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA. Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. Drug Healthc Patient Saf. 2013;5:191\u20138. https:\/\/doi.org\/10.2147\/DHPS.S48640.","journal-title":"Drug Healthc Patient Saf"},{"issue":"6","key":"2869_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4254\/wjh.v4.i6.196","volume":"4","author":"M Lahbabi","year":"2012","unstructured":"Lahbabi M, Aqodad N, Ibrahimi A, Lahlou M, Aqodad H. Acute hepatitis secondary to parenteral amiodarone does not preclude subsequent oral therapy. World J Hepatol. 2012;4(6):196\u20138. https:\/\/doi.org\/10.4254\/wjh.v4.i6.196.","journal-title":"World J Hepatol"},{"key":"2869_CR20","doi-asserted-by":"publisher","unstructured":"Rhodes A, Eastwood JB, Smith SA. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle? Gut. 1993;34(4):565\u20136. https:\/\/doi.org\/10.1136\/gut.34.4.565.","DOI":"10.1136\/gut.34.4.565"},{"key":"2869_CR21","doi-asserted-by":"publisher","unstructured":"Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E. The various effects of amiodarone on thyroid function. Thyroid. 2001;11(5): 511\u20139. https:\/\/doi.org\/10.1089\/105072501300176471.","DOI":"10.1089\/105072501300176471"},{"issue":"2","key":"2869_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.aohep.2019.09.010","volume":"19","author":"E Sticova","year":"2020","unstructured":"Sticova E, Jirsa M. ABCB4 disease: many faces of one gene deficiency. Ann Hepatol. 2020;19(2):126\u201333. https:\/\/doi.org\/10.1016\/j.aohep.2019.09.010.","journal-title":"Ann Hepatol"},{"key":"2869_CR23","doi-asserted-by":"publisher","unstructured":"Schomaker S, Potter D, Warner R, Larkindale J, King N, Porter AC et al. Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments. PLoS One. 2020;15(5). https:\/\/doi.org\/10.1371\/journal.pone.0229753.","DOI":"10.1371\/journal.pone.0229753"},{"issue":"15","key":"2869_CR24","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2217\/bmm-2021-0222","volume":"15","author":"KR Wagner","year":"2021","unstructured":"Wagner KR, Guglieri M, Ramaiah SK, Charnas L, Marraffino S, Binks M, et al. Safety and disease monitoring biomarkers in Duchenne muscular dystrophy: results from a phase II trial. Biomark Med. 2021;15(15):1389\u201396. https:\/\/doi.org\/10.2217\/bmm-2021-0222.","journal-title":"Biomark Med"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-02869-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T04:04:09Z","timestamp":1721707449000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-02869-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2869"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-02869-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"17 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"464"}}